BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34538264)

  • 1. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
    Wei X; Lou H; Zhou D; Jia Y; Li H; Huang Q; Ma J; Yang Z; Sun C; Meng Y; Xu S; Yang X; Li X; Ji T; Guo Z; Gao Q
    J Exp Clin Cancer Res; 2021 Sep; 40(1):292. PubMed ID: 34538264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation.
    McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK
    Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.
    Niu Y; Xia Y; Wang J; Shi X
    Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen content and extracellular matrix cause cytoskeletal remodelling in pancreatic fibroblasts.
    Stylianou A; Gkretsi V; Louca M; Zacharia LC; Stylianopoulos T
    J R Soc Interface; 2019 May; 16(154):20190226. PubMed ID: 31113335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
    Chen Z; He S; Zhan Y; He A; Fang D; Gong Y; Li X; Zhou L
    EBioMedicine; 2019 Sep; 47():208-220. PubMed ID: 31420300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
    Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
    J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway.
    Wang W; Du H; Liu H; Hu F; Liu G
    Oncol Rep; 2019 Jan; 41(1):668-676. PubMed ID: 30542716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
    Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
    PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
    Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
    Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression.
    Yu B; Chen X; Li J; Qu Y; Su L; Peng Y; Huang J; Yan J; Yu Y; Gu Q; Zhu Z; Liu B
    BMC Cell Biol; 2013 Mar; 14():17. PubMed ID: 23510049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate stiffness regulated migration and invasion ability of adenoid cystic carcinoma cells via RhoA/ROCK pathway.
    Zhao D; Li Q; Liu M; Ma W; Zhou T; Xue C; Cai X
    Cell Prolif; 2018 Jun; 51(3):e12442. PubMed ID: 29424004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
    Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
    Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 16. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
    Liu X; Chen D; Liu J; Chu Z; Liu D
    Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer.
    Wang C; Wang W; Liu Y; Yong M; Yang Y; Zhou H
    Cancer Sci; 2018 Jan; 109(1):84-93. PubMed ID: 29095547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness.
    Peng Y; Chen Z; Chen Y; Li S; Jiang Y; Yang H; Wu C; You F; Zheng C; Zhu J; Tan Y; Qin X; Liu Y
    Acta Biomater; 2019 Apr; 88():86-101. PubMed ID: 30771534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro.
    Xu Y; Pang X; Dong M; Wen F; Zhang Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):467-72. PubMed ID: 23764403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.
    Lai H; Zhao X; Qin Y; Ding Y; Chen R; Li G; Labrie M; Ding Z; Zhou J; Hu J; Ma D; Fang Y; Gao Q
    J Exp Clin Cancer Res; 2018 Feb; 37(1):32. PubMed ID: 29458390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.